MCID: CRB011
MIFTS: 66

Cerebrotendinous Xanthomatosis malady

Genetic diseases, Rare diseases, Neuronal diseases, Eye diseases, Liver diseases, Skin diseases, Metabolic diseases, Endocrine diseases categories

Aliases & Classifications for Cerebrotendinous Xanthomatosis

About this section
Sources:
45OMIM, 9Disease Ontology, 10diseasecard, 19GeneReviews, 41NIH Rare Diseases, 20GeneTests, 21Genetics Home Reference, 11DISEASES, 43Novoseek, 47Orphanet, 22GTR, 60UMLS, 55SNOMED-CT, 38NCIt, 33MeSH, 34MESH via Orphanet, 26ICD10 via Orphanet, 61UMLS via Orphanet
See all sources

Cerebrotendinous Xanthomatosis, Aliases & Descriptions:

Name: Cerebrotendinous Xanthomatosis 45 9 10 19 41 20 21 11 47
Ctx 19 41 21 47
Cholestanol Storage Disease 9 21 22
Cerebral Cholesterinosis 19 41 21
Sterol 27-Hydroxylase Deficiency 41 47
 
Xanthomatosis, Cerebrotendinous 21 60
Van Bogaert-Scherer-Epstein Disease 21
Cerebrotendinous Cholesterinosis 21
Xanthomatosis Cerebrotendinous 43


Classifications:



Characteristics (Orphanet epidemiological data):

47
cerebrotendinous xanthomatosis:
Inheritance: Autosomal recessive; Prevalence: 1-9/100000,<1/1000000 (Spain),1-9/100000 (United States); Age of onset: Infancy,Neonatal; Age of death: adult


External Ids:

OMIM45 213700
Disease Ontology9 DOID:4810
NCIt38 C84628
MeSH33 D019294
SNOMED-CT55 63246000
Orphanet47 909
MESH via Orphanet34 D019294
ICD10 via Orphanet26 E75.5
UMLS via Orphanet61 C0238052

Summaries for Cerebrotendinous Xanthomatosis

About this section


OMIM:45 Cerebrotendinous xanthomatosis is a rare inherited lipid-storage disease characterized clinically by progressive... (213700) more...

MalaCards based summary: Cerebrotendinous Xanthomatosis, also known as ctx, is related to xanthomatosis and osteoporosis, and has symptoms including cataract, multiple lipomas and involuntary movements. An important gene associated with Cerebrotendinous Xanthomatosis is CYP27A1 (cytochrome P450, family 27, subfamily A, polypeptide 1), and among its related pathways are Synthesis of bile acids and bile salts and Vitamin D synthesis. The compounds 24s-hydroxy-cholesterol and alfacalcidol have been mentioned in the context of this disorder. Affiliated tissues include brain, bone and lung, and related mouse phenotypes are skeleton and liver/biliary system.

Disease Ontology:9 A xanthomatosis that is characterized by a deficiency in the production of the bile acid, chenodeoxycholic acid that has material basis in autosomal recessive inheritance and results in cholestanol deposition in the brain and other tissues and with elevated levels of cholesterol in plasma.

Genetics Home Reference:21 Cerebrotendinous xanthomatosis is a fat (lipid) storage disorder that affects many areas of the body. People with this disorder cannot break down certain lipids effectively, specifically different forms of cholesterol, so these fats accumulate in various areas of the body. Xanthomatosis refers to the formation of fatty yellow nodules (xanthomas). Cerebrotendinous refers to the typical locations of the xanthomas (cerebro- meaning the brain and -tendinous meaning connective tissue called tendons that attach muscle to bone).

NIH Rare Diseases:41 Cerebrotendinous xanthomatosis is a type of lipid storage disease. symptoms of this condition include diarrhea in infants, cataracts in children, tendon xanthomas, and progressive neurologic dysfunction. it is caused by mutations in the cyp27a1 gene. treatment may involve chenodeoxycholic acid (cdca), inhibitors of hmg-coa reductase, and surgery to remove cataracts. last updated: 9/12/2013

GeneReviews summary for ctx

Related Diseases for Cerebrotendinous Xanthomatosis

About this section

Diseases related to Cerebrotendinous Xanthomatosis via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50)    (show all 125)
idRelated DiseaseScoreTop Affiliating Genes
1xanthomatosis32.5CYP7A1, APOB
2osteoporosis31.0CALCA, CYP27B1
3sitosterolemia30.9HMGCR, CYP7A1
4rickets30.6NR1H2, CYP27B1, CYP27A1
5coronary artery disease30.3APOA1, APOB, HMGCR
6acute myocardial infarction30.2APOA1, APOB, HMGCR
7rheumatoid arthritis30.0HMGCR, NR1H2, APOA1, CYP27B1
8osteoarthritis29.9NR1H2, NR1H4, CALCA
9myocardial infarction29.9HMGCR, APOB, APOA1, SP1
10arthritis29.8SP1, CALCA, NR1H2, HMGCR
11obesity29.4APOA1, APOB, NR1H4, NR1H2
12atherosclerosis29.3CYP27A1, CYP7A1, APOA1, APOB, NR1H4, NR1H2
13breast cancer29.2SP1, CYP27B1, CALCA, NR1H4, NR1H2
14cataract10.7
15pneumonia10.6
16ataxia10.6
17diarrhea10.5
18neuropathy10.5
19hepatitis10.5
20cerebritis10.5
21dystonia10.5
22peripheral neuropathy10.5
23polyneuropathy10.5
24reflex sympathetic dystrophy10.4CALCA
25bone fracture10.4
26oromandibular dystonia10.4
27artery disease10.4
28dementia10.4
29lipid storage disease10.4
30rickets, vitamin d-resistant, type iia10.3NR1H2, CYP27B1
31chylomicron retention disease10.3APOB
32intrahepatic cholestasis10.2NR1H4, NR1H2
33lymphangioleiomyomatosis10.2
34smith-lemli-opitz syndrome10.2
35cerebellar ataxia10.2
36vitamin d-dependent rickets, type i10.2
37tendinitis10.2
38liver disease10.2
39nephrolithiasis10.2
40thrombocytopenia10.2
41parametritis10.2
42blepharospasm10.2
43nephrocalcinosis10.2
44tabes dorsalis10.2
45gallbladder cancer10.2
46leukodystrophy10.2
47myopathy10.2
48tauopathy10.2
49neurologic diseases10.2
50aneurysm10.2

Graphical network of the top 20 diseases related to Cerebrotendinous Xanthomatosis:



Diseases related to cerebrotendinous xanthomatosis

Symptoms for Cerebrotendinous Xanthomatosis

About this section

Symptoms by clinical synopsis from OMIM:

213700

Clinical features from OMIM:

213700

Symptoms:

 47 (show all 31)
  • anomalies of eyes and vision
  • cataract/lens opacification
  • xanthomas/lipomas
  • myoclonus/fasciculations
  • intellectual deficit/mental/psychomotor retardation/learning disability
  • autosomal recessive inheritance
  • angor pectoris/myocardial infarction
  • arterial atheroma/precocious atherosclerosis/arteriosclerosis
  • midbrain/brainstem/pons/medulla anomalies
  • peripheral neuropathy
  • tremor
  • dystonia/torticollis/writer's cramp/blepharospasms
  • extrapyramidal syndrome
  • pyramidal syndrome
  • hypertonia/spasticity/rigidity/stiffness
  • hypereflexia
  • speech troubles/aphasia/dysphasia/echolalia/mutism/logorrhea/dysprosodia
  • psychic/psychomotor regression/dementia/intellectual decline
  • psychic/behavioural troubles
  • delirium/hallucination
  • humour troubles/anxiety/depression/apathy/euphoria/irritability
  • muscle weakness/flaccidity
  • hyperlipidemia/hypercholesterolemia/hypertriglyceridemia
  • malabsorption/chronic diarrhea/steatorrhea
  • hepatitis/icterus/cholestasis
  • urinary/renal lithiasis/kidney stones/nephritic colic
  • intracranial/cerebral calcifications
  • eeg anomalies
  • seizures/epilepsy/absences/spasms/status epilepticus
  • restricted joint mobility/joint stiffness/ankylosis
  • joint/articular deformation

HPO human phenotypes related to Cerebrotendinous Xanthomatosis:

(show all 51)
id Description Frequency HPO Source Accession
1 cataract hallmark (90%) HP:0000518
2 multiple lipomas hallmark (90%) HP:0001012
3 involuntary movements hallmark (90%) HP:0004305
4 cognitive impairment hallmark (90%) HP:0100543
5 hallucinations typical (50%) HP:0000738
6 hypertonia typical (50%) HP:0001276
7 muscle weakness typical (50%) HP:0001324
8 tremor typical (50%) HP:0001337
9 hyperreflexia typical (50%) HP:0001347
10 coronary artery disease typical (50%) HP:0001677
11 abnormality of extrapyramidal motor function typical (50%) HP:0002071
12 neurological speech impairment typical (50%) HP:0002167
13 developmental regression typical (50%) HP:0002376
14 abnormality of lipid metabolism typical (50%) HP:0003119
15 peripheral neuropathy typical (50%) HP:0009830
16 nephrolithiasis occasional (7.5%) HP:0000787
17 seizures occasional (7.5%) HP:0001250
18 limitation of joint mobility occasional (7.5%) HP:0001376
19 abnormality of the liver occasional (7.5%) HP:0001392
20 malabsorption occasional (7.5%) HP:0002024
21 eeg abnormality occasional (7.5%) HP:0002353
22 cerebral calcification occasional (7.5%) HP:0002514
23 autosomal recessive inheritance HP:0000007
24 cataract HP:0000518
25 optic disc pallor HP:0000543
26 dementia HP:0000726
27 hallucinations HP:0000738
28 delusions HP:0000746
29 osteoporosis HP:0000939
30 cholelithiasis HP:0001081
31 xanthelasma HP:0001114
32 intellectual disability HP:0001249
33 seizures HP:0001250
34 ataxia HP:0001251
35 spasticity HP:0001257
36 cerebellar atrophy HP:0001272
37 myocardial infarction HP:0001658
38 angina pectoris HP:0001681
39 diarrhea HP:0002014
40 cerebral atrophy HP:0002059
41 respiratory insufficiency HP:0002093
42 abnormality of the periventricular white matter HP:0002518
43 abnormality of cholesterol metabolism HP:0003107
44 emg HP:0003482
45 pseudobulbar paralysis HP:0007024
46 abnormality of pyramidal motor function HP:0007256
47 peripheral neuropathy HP:0009830
48 eeg with generalized slow activity HP:0010845
49 tendon xanthomatosis HP:0010874
50 abnormality of central somatosensory evoked potentials HP:0100291
51 abnormality of the dentate nucleus HP:0100321

Drugs & Therapeutics for Cerebrotendinous Xanthomatosis

About this section

Drug clinical trials:

Search ClinicalTrials for Cerebrotendinous Xanthomatosis

Search NIH Clinical Center for Cerebrotendinous Xanthomatosis

Genetic Tests for Cerebrotendinous Xanthomatosis

About this section

Genetic tests related to Cerebrotendinous Xanthomatosis:

id Genetic test Affiliating Genes
1 Cerebrotendinous Xanthomatosis20 CYP27A1
2 Cholestanol Storage Disease22

Anatomical Context for Cerebrotendinous Xanthomatosis

About this section

MalaCards organs/tissues related to Cerebrotendinous Xanthomatosis:

31
Brain, Bone, Lung, Liver, Spinal cord, Eye, Skin, Kidney, Testes, Pons, Heart

Animal Models for Cerebrotendinous Xanthomatosis or affiliated genes

About this section

MGI Mouse Phenotypes related to Cerebrotendinous Xanthomatosis:

35
idDescriptionMGI Source AccessionScoreTop Affiliating Genes
1MP:00053908.3NR1H2, NR1H4, CALCA, CYP27B1, SP1
2MP:00053707.6SP1, CYP27A1, CYP7A1, APOA1, APOB, NR1H4
3MP:00107717.4NR1H2, SP1, CYP7A1, CYP27B1, APOA1, FLNC
4MP:00053857.1SP1, APOA1, APOB, FLNC, CALCA, NR1H4
5MP:00107686.8SP1, CYP7A1, APOB, FLNC, CALCA, NR1H4
6MP:00053766.7SP1, CYP27A1, CYP7A1, CYP27B1, APOA1, APOB

Publications for Cerebrotendinous Xanthomatosis

About this section

Articles related to Cerebrotendinous Xanthomatosis:

(show top 50)    (show all 369)
idTitleAuthorsYear
1
A suspicion index for early diagnosis and treatment of cerebrotendinous xanthomatosis. (24442603)
2014
2
Cerebrotendinous xanthomatosis--the spectrum of imaging findings. (23705046)
2013
3
Fluoxetine-responsive depression in a Chinese cerebrotendinous xanthomatosis. (22133984)
2012
4
Myoclonus and dystonia in cerebrotendinous xanthomatosis. (23115103)
2012
5
A case of cerebrotendinous xanthomatosis presenting with epilepsy as an initial symptom with a novel V413D mutation in the CYP27A1 gene. (22336472)
2012
6
Leukodystrophy with a cerebellar cystic aspect and intracranial atherosclerosis: an atypical presentation of cerebrotendinous xanthomatosis. (21769531)
2012
7
Atypical parkinsonism and cerebrotendinous xanthomatosis: report of a family with corticobasal syndrome and a literature review. (23124517)
2012
8
Botulinum toxin-responsive oromandibular dystonia in cerebrotendinous xanthomatosis. (21531161)
2011
9
Cerebrotendinous xanthomatosis: a rare cause of spinocerebellar syndrome. (22212991)
2011
10
Cerebrotendinous xanthomatosis]. (19034999)
2008
11
Cerebrotendinous xanthomatosis: report of two Brazilian brothers. (15608974)
2004
12
Cerebrotendinous xanthomatosis: neuroimaging findings in two siblings from an Indian family. (14652454)
2003
13
Cerebrotendinous xanthomatosis with psychiatric disorders: report of three siblings and literature review. (12141707)
2002
14
A case of familial type IIa hypercholesterolemia with the clinical features similar to cerebrotendinous xanthomatosis]. (10885331)
2000
15
Clinical and molecular genetic characteristics of patients with cerebrotendinous xanthomatosis. (10775536)
2000
16
Mutations producing premature termination of translation and an amino acid substitution in the sterol 27-hydroxylase gene cause cerebrotendinous xanthomatosis associated with parkinsonism. (10406988)
1999
17
Genetic analysis enables definite and rapid diagnosis of cerebrotendinous xanthomatosis. (9748042)
1998
18
Partial deletion of the gene encoding sterol 27-hydroxylase in a subject with cerebrotendinous xanthomatosis. (8728327)
1996
19
A novel mutation in the cytochrome P450(27) (CYP27) gene caused cerebrotendinous xanthomatosis in a Japanese family. (8728324)
1996
20
Determination of the glucurono-conjugated position in bile alcohol glucuronides present in a patient with cerebrotendinous xanthomatosis. (8539780)
1995
21
Premature termination codon at the sterol 27-hydroxylase gene causes cerebrotendinous xanthomatosis in a French family. (7860076)
1995
22
Historical aspects of cerebrotendinous xanthomatosis (CTX). (11619019)
1995
23
Ocular and systemic manifestations of cerebrotendinous xanthomatosis. (7485361)
1995
24
Determination of the glucurono-conjugated position in bile alcohol glucuronides excreted in urine of a patient with cerebrotendinous xanthomatosis by a nuclear magnetic resonance study. (8089079)
1994
25
Biochemical studies of inherited diseases related to abnormal cholesterol metabolism. I. High-performance liquid chromatographic analysis of bile alcohol glucuronides in cerebrotendinous xanthomatosis. (7920441)
1994
26
Premature termination codon at the sterol 27-hydroxylase gene causes cerebrotendinous xanthomatosis in an Afrikaner family. (8162025)
1994
27
Cerebrotendinous Xanthomatosis (20301583)
1993
28
Osteoporosis and increased bone fractures in cerebrotendinous xanthomatosis. (8231848)
1993
29
Treatment of cerebrotendinous xanthomatosis with low-density lipoprotein (LDL)-apheresis. (8445406)
1993
30
Radioimmunoassay of 5 beta-cholestane-3 alpha,7 alpha,12 alpha,25-tetrol 3-glucuronide in serum of patients with cerebrotendinous xanthomatosis. (1585391)
1992
31
Evoked potentials in cerebrotendinous xanthomatosis and effect induced by chenodeoxycholic acid. (1316120)
1992
32
Paediatric cerebrotendinous xanthomatosis. (1405473)
1992
33
Juvenile cataract associated with chronic diarrhea in pediatric cerebrotendinous xanthomatosis. (1951610)
1991
34
Cerebrotendinous xanthomatosis: clinical and MRI study (a case report). (2303834)
1990
35
Cerebrotendinous xanthomatosis. (2329221)
1990
36
Cerebrotendinous xanthomatosis. (2493565)
1989
37
Low-density lipoprotein metabolism in cerebrotendinous xanthomatosis. (3821507)
1987
38
Accumulation of 7 alpha-hydroxy-4-cholesten-3-one and cholesta-4,6-dien-3-one in patients with cerebrotendinous xanthomatosis: effect of treatment with chenodeoxycholic acid. (3557306)
1987
39
Bile acid profiles in bile, urine, and feces of a patient with cerebrotendinous xanthomatosis. (3660436)
1986
40
Peripheral neuropathy in cerebrotendinous xanthomatosis. (2994606)
1985
41
Diagnosis of cerebrotendinous xanthomatosis (CTX) and effect of chenodeoxycholic acid therapy by analysis of urine using capillary gas chromatography. (6883710)
1983
42
Cerebrotendinous xanthomatosis: A cause of cataracts and tendon xanthoma. (6805326)
1982
43
A unique patient with coexisting cerebrotendinous xanthomatosis and beta-sitosterolemia. (7258222)
1981
44
Assay of intermediates in bile acid biosynthesis using isotope dilution--mass spectrometry: hepatic levels in the normal state and in cerebrotendinous xanthomatosis. (7017048)
1981
45
Peripheral neuropathy in cerebrotendinous xanthomatosis. (221858)
1979
46
Configurational assignment of 5 beta-cholestane-3 alpha, 7 alpha, 12 alpha, 23, 25-pentol excreted by patients with cerebrotendinous xanthomatosis (a circular dichroism study). (442127)
1979
47
Identifications of 5 beta-cholestane-3 alpha, 7 alpha, 12 alpha, 23 beta-tetrol, 5 beta-cholestane-3 alpha, 7 alpha, 12 alpha, 24 alpha-tetrol, and 5 beta-cholestane-3 alpha, 7 alpha, 12 alpha, 24 beta-tetrol in cerebrotendinous xanthomatosis. (663972)
1978
48
Absolute configuration of pentahydroxy bile alcohols excreted by patients with cerebrotendinous xanthomatosis: a circular dichroism study. (632682)
1978
49
Chenodeoxycholic acid inhibits increased cholesterol and cholestanol synthesis in patients with cerebrotendinous xanthomatosis. (1212241)
1975
50
Cholestanol deposition in cerebrotendinous xanthomatosis. A possible mechanism. (5134895)
1971

Variations for Cerebrotendinous Xanthomatosis

About this section

UniProtKB/Swiss-Prot genetic disease variations for Cerebrotendinous Xanthomatosis:

62
id Symbol AA change Variation ID SNP ID
1CYP27A1p.Arg395CysVAR_001303
2CYP27A1p.Arg479CysVAR_001304
3CYP27A1p.Arg395SerVAR_012285
4CYP27A1p.Arg405GlnVAR_012286
5CYP27A1p.Arg474GlnVAR_012287
6CYP27A1p.Arg474TrpVAR_012288
7CYP27A1p.Gly145GluVAR_016966

Clinvar genetic disease variations for Cerebrotendinous Xanthomatosis:

6 (show all 62)
id Gene Variation Type Significance SNP ID Assembly Location
1CYP27A1NM_000784.3(CYP27A1): c.1435C> T (p.Arg479Cys)single nucleotide variantPathogenicrs72551322GRCh37Chr 2, 219679439: 219679439
2CYP27A1NM_000784.3(CYP27A1): c.1183C> T (p.Arg395Cys)single nucleotide variantPathogenicrs121908096GRCh37Chr 2, 219678909: 219678909
3CYP27A1NM_000784.3(CYP27A1): c.845-1G> Asingle nucleotide variantPathogenicrs397515353GRCh37Chr 2, 219677646: 219677646
4CYP27A1NM_000784.3(CYP27A1): c.844+1G> Asingle nucleotide variantPathogenicrs397515354GRCh37Chr 2, 219677473: 219677473
5CYP27A1NM_000784.3(CYP27A1): c.1421G> A (p.Arg474Gln)single nucleotide variantPathogenicrs121908097GRCh37Chr 2, 219679425: 219679425
6CYP27A1NM_000784.3(CYP27A1): c.1420C> T (p.Arg474Trp)single nucleotide variantPathogenicrs121908098GRCh37Chr 2, 219679424: 219679424
7CYP27A1NM_000784.3(CYP27A1): c.1214G> A (p.Arg405Gln)single nucleotide variantPathogenicrs121908099GRCh37Chr 2, 219679132: 219679132
8CYP27A1NM_000784.3(CYP27A1): c.1183C> A (p.Arg395Ser)single nucleotide variantPathogenicrs121908096GRCh37Chr 2, 219678909: 219678909
9CYP27A1NM_000784.3(CYP27A1): c.1263+1G> Asingle nucleotide variantPathogenicrs397515355GRCh37Chr 2, 219679182: 219679182
10CYP27A1NM_000784.3(CYP27A1): c.434G> A (p.Gly145Glu)single nucleotide variantPathogenicrs72551313GRCh37Chr 2, 219674478: 219674478
11CYP27A1NM_000784.3(CYP27A1): c.944_948delTGGCC (p.Leu315Glnfs)deletionPathogenicrs397515356GRCh37Chr 2, 219677746: 219677750
12CYP27A1NM_000784.3(CYP27A1): c.1016C> T (p.Thr339Met)single nucleotide variantPathogenicrs121908102GRCh37Chr 2, 219677818: 219677818
13CYP27A1NM_000784.3(CYP27A1): c.1435C> G (p.Arg479Gly)single nucleotide variantPathogenicrs72551322GRCh37Chr 2, 219679439: 219679439
14CYP27A1NM_000784.3(CYP27A1): c.1017G> C (p.Thr339=)single nucleotide variantPathogenicGRCh37Chr 2, 219677819: 219677819
15CYP27A1NM_000784.3(CYP27A1): c.1061A> G (p.Asp354Gly)single nucleotide variantPathogenicGRCh37Chr 2, 219678787: 219678787
16CYP27A1NM_000784.3: c.10_11 ins10bpinsertionPathogenic
17CYP27A1NM_000784.3: c.1146_1151delinsinsertionPathogenic
18CYP27A1NM_000784.3(CYP27A1): c.1151C> T (p.Pro384Leu)single nucleotide variantPathogenicGRCh37Chr 2, 219678877: 219678877
19CYP27A1NM_000784.3: c.1180-1181delCTdeletionPathogenic
20CYP27A1NM_000784.3(CYP27A1): c.1184+1G> Asingle nucleotide variantPathogenicGRCh37Chr 2, 219678911: 219678911
21CYP27A1NM_000784.3(CYP27A1): c.1184G> A (p.Arg395His)single nucleotide variantPathogenicGRCh37Chr 2, 219678910: 219678910
22CYP27A1NM_000784.3(CYP27A1): c.1185-1G> Tsingle nucleotide variantPathogenicGRCh37Chr 2, 219679102: 219679102
23CYP27A1NM_000784.3(CYP27A1): c.1202C> G (p.Pro401Arg)single nucleotide variantPathogenicGRCh37Chr 2, 219679120: 219679120
24CYP27A1NM_000784.3(CYP27A1): c.1209C> G (p.Asn403Lys)single nucleotide variantPathogenicGRCh37Chr 2, 219679127: 219679127
25CYP27A1NM_000784.3(CYP27A1): c.1213C> T (p.Arg405Trp)single nucleotide variantPathogenicGRCh37Chr 2, 219679131: 219679131
26CYP27A1NM_000784.3(CYP27A1): c.1222G> T (p.Glu408Ter)single nucleotide variantPathogenicGRCh37Chr 2, 219679140: 219679140
27CYP27A1NM_000784.3(CYP27A1): c.1238T> A (p.Val413Asp)single nucleotide variantPathogenicGRCh37Chr 2, 219679156: 219679156
28CYP27A1NM_000784.3(CYP27A1): c.1263+5G> Tsingle nucleotide variantPathogenicGRCh37Chr 2, 219679186: 219679186
29CYP27A1NM_000784.3: c.1263+81_1596+?deldeletionPathogenic
30CYP27A1NM_000784.3(CYP27A1): c.1264-1G> Asingle nucleotide variantPathogenicGRCh37Chr 2, 219679267: 219679267
31CYP27A1NM_000784.3: c.1323C> Tsingle nucleotide variantPathogenic
32CYP27A1NM_000784.3: c.1330-1333delTTCCdeletionPathogenic
33CYP27A1NM_000784.3(CYP27A1): c.1402C> T (p.Pro468Ser)single nucleotide variantPathogenicGRCh37Chr 2, 219679406: 219679406
34CYP27A1NM_000784.3(CYP27A1): c.1415G> C (p.Gly472Ala)single nucleotide variantPathogenicGRCh37Chr 2, 219679419: 219679419
35CYP27A1NM_000784.3(CYP27A1): c.305delC (p.Pro102Leufs)deletionPathogenicGRCh37Chr 2, 219674349: 219674349
36CYP27A1NM_000784.3(CYP27A1): c.355delC (p.Arg119Glyfs)deletionPathogenicGRCh37Chr 2, 219674399: 219674399
37CYP27A1NM_000784.3(CYP27A1): c.369_375delGTACCCA (p.Pro125Glyfs)deletionPathogenicGRCh37Chr 2, 219674413: 219674419
38CYP27A1NM_000784.3(CYP27A1): c.379C> T (p.Arg127Trp)single nucleotide variantPathogenicGRCh37Chr 2, 219674423: 219674423
39CYP27A1NM_000784.3(CYP27A1): c.380G> A (p.Arg127Gln)single nucleotide variantPathogenicGRCh37Chr 2, 219674424: 219674424
40CYP27A1NM_000784.3(CYP27A1): c.409C> T (p.Arg137Trp)single nucleotide variantPathogenicGRCh37Chr 2, 219674453: 219674453
41CYP27A1NM_000784.3(CYP27A1): c.433G> A (p.Gly145Arg)single nucleotide variantPathogenicGRCh37Chr 2, 219674477: 219674477
42CYP27A1NM_000784.3(CYP27A1): c.435G> T (p.Gly145=)single nucleotide variantPathogenicGRCh37Chr 2, 219674479: 219674479
43CYP27A1NM_000784.3(CYP27A1): c.446+1G> Asingle nucleotide variantPathogenicGRCh37Chr 2, 219674491: 219674491
44CYP27A1NM_000784.3(CYP27A1): c.475C> T (p.Gln159Ter)single nucleotide variantPathogenicGRCh37Chr 2, 219676973: 219676973
45CYP27A1NM_000784.3: c.525-526delGdeletionPathogenic
46CYP27A1NM_000784.3(CYP27A1): c.583G> T (p.Glu195Ter)single nucleotide variantPathogenicGRCh37Chr 2, 219677081: 219677081
47CYP27A1NM_000784.3: c.599C> Tsingle nucleotide variantPathogenic
48CYP27A1NM_000784.3(CYP27A1): c.5dupC (p.Ala3Cysfs)duplicationPathogenicGRCh37Chr 2, 219646910: 219646911
49CYP27A1NM_000784.3(CYP27A1): c.646G> C (p.Ala216Pro)single nucleotide variantPathogenicGRCh37Chr 2, 219677144: 219677144
50CYP27A1NM_000784.3(CYP27A1): c.647-1G> Tsingle nucleotide variantPathogenicGRCh37Chr 2, 219677274: 219677274
51CYP27A1NM_000784.3(CYP27A1): c.691C> T (p.Arg231Ter)single nucleotide variantPathogenicGRCh37Chr 2, 219677319: 219677319
52CYP27A1NM_000784.3(CYP27A1): c.73delG (p.Ala25Profs)deletionPathogenicGRCh37Chr 2, 219646978: 219646978
53CYP27A1NM_000784.3(CYP27A1): c.745C> T (p.Gln249Ter)single nucleotide variantPathogenicGRCh37Chr 2, 219677373: 219677373
54CYP27A1NM_000784.3(CYP27A1): c.752C> A (p.Ser251Ter)single nucleotide variantPathogenicGRCh37Chr 2, 219677380: 219677380
55CYP27A1NM_000784.3(CYP27A1): c.776A> G (p.Lys259Arg)single nucleotide variantPathogenicGRCh37Chr 2, 219677404: 219677404
56CYP27A1NM_000784.3(CYP27A1): c.779G> A (p.Trp260Ter)single nucleotide variantPathogenicGRCh37Chr 2, 219677407: 219677407
57CYP27A1NM_000784.3(CYP27A1): c.808C> T (p.Arg270Ter)single nucleotide variantPathogenicGRCh37Chr 2, 219677436: 219677436
58CYP27A1NM_000784.3(CYP27A1): c.819delT (p.Asp273Glufs)deletionPathogenicGRCh37Chr 2, 219677447: 219677447
59CYP27A1NM_000784.3(CYP27A1): c.850A> T (p.Lys284Ter)single nucleotide variantPathogenicGRCh37Chr 2, 219677652: 219677652
60CYP27A1NM_000784.3(CYP27A1): c.863delA (p.Glu288Glyfs)deletionPathogenicGRCh37Chr 2, 219677665: 219677665
61CYP27A1NM_000784.3(CYP27A1): c.410G> A (p.Arg137Gln)single nucleotide variantPathogenicGRCh37Chr 2, 219674454: 219674454
62CYP27A1NP_000775.1: p.Trp133*undetermined variantPathogenic

Expression for genes affiliated with Cerebrotendinous Xanthomatosis

About this section
Search GEO for disease gene expression data for Cerebrotendinous Xanthomatosis.

Pathways for genes affiliated with Cerebrotendinous Xanthomatosis

About this section

Pathways related to Cerebrotendinous Xanthomatosis according to GeneCards Suite gene sharing:

(show all 19)
idSuper pathways (with members indented)ScoreTop Affiliating Genes
1
Show member pathways
9.9CYP7A1, CYP27A1
29.9CYP27A1, CYP27B1
3
Show member pathways
Cholesterol biosynthesis36
lanosterol biosynthesis36
zymosterol biosynthesis36
mevalonate pathway I36
epoxysqualene biosynthesis36
cholesterol biosynthesis II (via 24,25-dihydrolanosterol)36
superpathway of geranylgeranyldiphosphate biosynthesis I (via mevalonate)36
trans, trans-farnesyl diphosphate biosynthesis36
cholesterol biosynthesis I36
cholesterol biosynthesis III (via desmosterol)36
geranylgeranyldiphosphate biosynthesis36
9.9HMGCR, CYP27B1
49.8NR1H4, CYP7A1
5
Show member pathways
9.6CYP27A1, CYP7A1, CYP27B1
6
Show member pathways
9.6CYP27B1, CYP7A1, CYP27A1
79.5CYP7A1, CYP27B1, NR1H4
89.5CYP7A1, NR1H4, HMGCR
99.5APOA1, SP1
10
Show member pathways
fatty acid beta-oxidation VI (peroxisome)36
9.5APOA1, CYP7A1, CYP27A1
11
Show member pathways
9.4APOB, APOA1
12
Show member pathways
9.4APOB, APOA1
139.4APOB, APOA1
14
Show member pathways
FOXA transcription factor networks36
9.3SP1, APOB
15
Show member pathways
9.2HMGCR, NR1H2, SP1
16
Show member pathways
8.9SP1, CYP7A1, APOA1, HMGCR
17
Show member pathways
8.8HMGCR, APOB, APOA1, CYP7A1
18
Show member pathways
6.9SP1, CYP27A1, CYP7A1, CYP27B1, APOA1, APOB

Compounds for genes affiliated with Cerebrotendinous Xanthomatosis

About this section

Compounds related to Cerebrotendinous Xanthomatosis according to GeneCards Suite gene sharing:

(show top 50)    (show all 147)
idCompoundScoreTop Affiliating Genes
124s-hydroxy-cholesterol439.9CYP27A1, CYP7A1, HMGCR
2alfacalcidol43 59 1211.7CYP27A1, CYP27B1, CALCA
37alpha-hydroxy-4-cholesten-3-one439.6CYP27A1, CYP7A1, NR1H2, HMGCR
427-hydroxycholesterol43 2810.6CYP27A1, NR1H2, HMGCR, CYP7A1
5sitosterol439.6HMGCR, APOB, CYP7A1
6cholestyramine439.5APOB, CYP7A1, HMGCR
7bile acid439.5HMGCR, NR1H2, NR1H4, CYP7A1
8lathosterol43 2410.5HMGCR, CYP7A1, APOB
9colestipol439.5APOB, APOA1, HMGCR
10ursodeoxycholic acid43 24 1211.4HMGCR, NR1H2, NR1H4, CYP7A1
11lithocholic acid43 28 2411.4CYP7A1, NR1H2, NR1H4
12campesterol43 2410.4HMGCR, APOA1, APOB
13fenofibric acid43 2810.4APOB, HMGCR, APOA1
14acipimox43 2810.3HMGCR, APOA1, APOB
157-ketocholesterol43 2410.2APOB, HMGCR, CYP27A1, APOA1
16cholesterol ester439.2HMGCR, CYP7A1, APOA1, APOB
17bezafibrate43 28 1211.2APOB, HMGCR, APOA1, CYP7A1
18ciprofibrate43 2810.1APOA1, APOB, HMGCR, NR1H2
19tocopherol439.1APOB, HMGCR, NR1H2, APOA1
20ezetimibe43 1210.1HMGCR, NR1H2, APOA1, APOB
21pravastatin43 49 28 24 1213.0HMGCR, APOB, CYP7A1, APOA1
22fenofibrate43 49 1211.0NR1H2, APOA1, APOB, HMGCR
23probucol43 1210.0HMGCR, APOB, APOA1
24tibolone438.9CALCA, APOB, APOA1
25atorvastatin43 49 28 24 1212.9APOA1, CYP7A1, APOB, HMGCR
26kininogen438.9NR1H4, APOB, NR1H2, APOA1
27retinoid438.9CYP27A1, SP1, NR1H4, NR1H2, CYP27B1
28alpha tocopherol438.8HMGCR, APOA1, APOB, NR1H2
2922r-hydroxycholesterol43 289.8NR1H2, APOA1, FDX1, NR1H4
30simvastatin43 49 59 28 24 1213.7HMGCR, APOB, APOA1, CYP27A1, SP1
31chenodeoxycholic acid43 28 24 1211.6APOB, CYP7A1, NR1H4, NR1H2, HMGCR, CYP27A1
32prostacyclin438.6SP1, HMGCR, NR1H2, APOA1, CYP7A1, CYP27A1
3325-hydroxyvitamin d438.5CYP27B1, CALCA, FDX1, APOA1, CYP27A1
34thyroxine43 249.5HMGCR, NR1H2, CALCA, APOB, APOA1
35progestin438.5APOA1, SP1, NR1H2, FDX1
36calcitriol43 59 24 1211.5CALCA, CYP27B1, CYP27A1, NR1H4, NR1H2, SP1
37vitamin d438.5NR1H4, CALCA, CYP27B1, CYP27A1, SP1, NR1H2
38taurocholate438.5NR1H2, APOB, NR1H4, APOA1, CYP7A1, HMGCR
39genistein43 28 59 2 24 1213.3NR1H2, CYP27B1, SP1, APOB, APOA1
40pge2438.3APOA1, CALCA, SP1, NR1H2, CYP27B1
41nadph43 249.2HMGCR, CYP27A1, CYP27B1, CYP7A1, FDX1
42retinoic acid43 249.2APOA1, CYP27B1, CYP7A1, SP1, CYP27A1, NR1H4
431,25 dihydroxy vitamin d3438.1CALCA, FDX1, CYP27B1, CYP27A1, NR1H2, SP1
44steroid437.9CYP27B1, CYP7A1, SP1, CYP27A1, FDX1, NR1H4
45estrogen437.4APOA1, SP1, CYP7A1, NR1H4, CALCA, APOB
46cholesterol43 28 24 1210.1APOA1, APOB, FDX1, NR1H4, NR1H2, HMGCR
47lipid437.0NR1H4, FDX1, APOA1, NR1H2, HMGCR, APOB
48testosterone43 59 24 129.9CYP27B1, APOA1, NR1H2, CALCA, FDX1, APOB
49sterol436.8NR1H2, FDX1, APOA1, HMGCR, NR1H4, APOB
50dexamethasone43 49 28 129.8NR1H2, APOA1, CYP7A1, CYP27A1, SP1, APOB

GO Terms for genes affiliated with Cerebrotendinous Xanthomatosis

About this section

Cellular components related to Cerebrotendinous Xanthomatosis according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1very-low-density lipoprotein particleGO:00343619.4APOB, APOA1
2endocytic vesicle lumenGO:00716829.1APOB, APOA1

Biological processes related to Cerebrotendinous Xanthomatosis according to GeneCards Suite gene sharing:

(show all 18)
idNameGO IDScoreTop Affiliating Genes
1regulation of bile acid biosynthetic processGO:007085710.1NR1H4, CYP7A1
2sterol metabolic processGO:001612510.1CYP7A1, CYP27A1
3bile acid biosynthetic processGO:000669910.0CYP7A1, CYP27A1
4bile acid metabolic processGO:00082069.8CYP27A1, CYP7A1, NR1H4
5xenobiotic metabolic processGO:00068059.7CYP27A1, CYP7A1, CYP27B1
6endothelial cell proliferationGO:00019359.7APOA1, CALCA
7positive regulation of lipid storageGO:00108849.7NR1H2, APOB
8lipoprotein biosynthetic processGO:00421589.7APOA1, APOB
9cholesterol transportGO:00303019.6APOB, APOA1
10response to lipopolysaccharideGO:00324969.4NR1H4, APOB, CYP27B1
11cholesterol biosynthetic processGO:00066959.4HMGCR, APOA1
12lipoprotein metabolic processGO:00421579.4APOB, APOA1
13cholesterol effluxGO:00333449.3APOA1, APOB
14transcription initiation from RNA polymerase II promoterGO:00063679.2NR1H2, NR1H4, SP1
15cholesterol homeostasisGO:00426329.0CYP7A1, APOA1, APOB, NR1H2
16cellular lipid metabolic processGO:00442558.8HMGCR, NR1H2, APOA1, CYP7A1, SP1
17cholesterol metabolic processGO:00082038.6FDX1, APOB, APOA1, CYP27A1
18small molecule metabolic processGO:00442817.2SP1, CYP27A1, CYP7A1, CYP27B1, APOA1, APOB

Molecular functions related to Cerebrotendinous Xanthomatosis according to GeneCards Suite gene sharing:

(show all 7)
idNameGO IDScoreTop Affiliating Genes
1heme bindingGO:00200379.7CYP27B1, CYP7A1, CYP27A1
2retinoid X receptor bindingGO:00469659.7NR1H2, NR1H4
3steroid hormone receptor activityGO:00037079.7NR1H2, NR1H4
4cholesterol transporter activityGO:00171279.5APOA1, APOB
5ligand-activated sequence-specific DNA binding RNA polymerase II transcription factor activityGO:00048799.4NR1H2, NR1H4
6iron ion bindingGO:00055069.0FDX1, CYP27B1, CYP7A1, CYP27A1
7protein bindingGO:00055156.8SP1, APOA1, APOB, FLNC, CALCA, NR1H4

Products for genes affiliated with Cerebrotendinous Xanthomatosis

About this section
  • Antibodies
  • Proteins
  • Lysates
  • Antibodies
  • Proteins
  • Kits and Assays

Sources for Cerebrotendinous Xanthomatosis

About this section
3CDC
13ExPASy
14FMA
22GTR
23HGMD
24HMDB
25ICD10
26ICD10 via Orphanet
27ICD9CM
28IUPHAR
29KEGG
33MeSH
34MESH via Orphanet
35MGI
38NCIt
39NDF-RT
42NINDS
43Novoseek
45OMIM
46OMIM via Orphanet
50PubMed
51QIAGEN
56SNOMED-CT via Orphanet
60UMLS
61UMLS via Orphanet